Table 1.
Clinical and biochemical characteristics of hypertension group and control group (x±s).
| Indicator | Hypertension group (n=360) | Control Group (n=360) |
χ
2/t value |
P value |
|---|---|---|---|---|
| Age | 58.27±15.08 | 58.91±13.16 | -0.600 | 0.548 |
| Gender | 0.358 | 0.549 | ||
| Female | 168(46.7) | 160(44.4) | ||
| Male | 192(53.3) | 200(55.6) | ||
| SBP(mmHg) | 150.29±9.83 | 116.73±10.56 | 44.117 | 0.001 |
| DBP(mmHg) | 79.97±11.42 | 70.00±7.06 | 14.090 | 0.001 |
| BMI(kg/m2) | 24.47±3.38 | 23.82±2.42 | 2.978 | 0.003 |
| FGLU(mmol/L) | 5.49±0.93 | 5.36±0.80 | 2.043 | 0.041 |
| FIN(mIU/L) | 11.48±1.78 | 11.50±1.88 | -0.156 | 0.876 |
| HOMA | 1.96±0.58 | 1.93±0.41 | 0.857 | 0.392 |
| TC(mmol/L) | 4.74±1.03 | 4.63±1.19 | 1.250 | 0.212 |
| TG(mmol/L) | 1.85±0.59 | 1.61±0.44 | 6.108 | 0.001 |
| LDL(mmol/L) | 3.20±0.84 | 2.79±0.81 | 6.617 | 0.001 |
| HDL(mmol/L) | 1.09±0.27 | 1.24±0.33 | -6.702 | 0.001 |
| CRP(mg/L) | 7.20±2.14 | 6.16±1.31 | 7.850 | 0.001 |
| LVMI(gym2) | 116.82±18.30 | 83.71±24.83 | 20.365 | 0.001 |
| UACR(mg/mmol) | 2.25±0.64 | 1.53±0.47 | 17.227 | 0.001 |
| APN(mg/L) | 6.44±1.67 | 9.91±1.97 | -25.554 | 0.001 |
| CTRP1(ug/L) | 11.70±3.09 | 8.22±1.41 | 19.456 | 0.001 |
| TNFa(ng/L) | 66.44±22.81 | 35.24±3.75 | 25.609 | 0.001 |
| IL6(ng/L) | 21.54±5.76 | 14.34±2.02 | 22.356 | 0.001 |